900 Participants Needed

In-Person vs. Virtual Therapy for Postpartum Depression

GR
Overseen ByGalena Rhoades, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines whether a group therapy program for preventing postpartum depression is as effective online as it is in person. The therapy, known as the ROSE Program (Reach Out, Stay Strong, Essentials for mothers of newborns), supports new mothers with social support and communication skills and is available in both English and Spanish. The trial suits pregnant women who are less than 30 weeks along and wish to explore different ways to manage their mental health after giving birth. Participants can choose to attend sessions in person or via Zoom. As an unphased trial, this study provides a unique opportunity for participants to explore innovative mental health support options during a crucial time.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the ROSE Program, available both in person and online, helps prevent postpartum depression (PPD) in new mothers. This program teaches skills and provides information to lower the risk of PPD. Studies have found that participants well-receive the in-person version of the ROSE Program, finding the sessions helpful for managing emotional changes after childbirth.

The online version of the ROSE Program mirrors the structure of the in-person one. Although newer, the online sessions aim to offer the same support and benefits. So far, no specific negative effects have been reported for either version of the program.

Overall, both in-person and online sessions of the ROSE Program are considered safe based on current information. Participants usually find the program helpful and practical for supporting their mental health after having a baby.12345

Why are researchers excited about this trial?

Researchers are excited about the ROSE Program for postpartum depression because it offers flexibility and accessibility that current treatments might lack. Unlike traditional in-person therapy sessions, the ROSE Program includes a virtual delivery option, making it easier for new mothers to participate from home via Zoom. This dual approach not only provides the same content and support as in-person therapy but also reduces barriers such as transportation challenges, particularly through the provision of Uber rides for those attending in person. The program's focus on social support, communication, and role transition to motherhood addresses key areas that can significantly impact postpartum depression outcomes. This innovative blend of accessibility and comprehensive support is what sets the ROSE Program apart from standard care options.

What evidence suggests that this trial's treatments could be effective for postpartum depression?

Research has shown that the ROSE Program, when conducted in person, helps prevent postpartum depression. This program supports new mothers by focusing on social support, adjusting to their new role, improving communication skills, and teaching about postpartum depression. Studies have found that women who attend in-person ROSE sessions experience lower rates of depression after having a baby.

This trial tests the online version of the ROSE Program as a separate treatment arm to determine its effectiveness compared to in-person sessions. Early results suggest that virtual sessions can also provide the support and education needed to help prevent postpartum depression. Offering the program online may make it easier for more women to access this important support from home.12346

Who Is on the Research Team?

GR

Galena Rhoades, PhD

Principal Investigator

University of Denver

EP

Elysia P Davis, PhD

Principal Investigator

University of Denver

Are You a Good Fit for This Trial?

This trial is for English or Spanish-speaking individuals who are less than 30 weeks into their pregnancy. It's designed to help prevent postpartum depression and there are no specific exclusion criteria, meaning it's quite open for participants.

Inclusion Criteria

Less than 30 gestational weeks

Exclusion Criteria

Not applicable.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the ROSE program, consisting of four 90-minute weekly group sessions and one individual booster session, delivered either in-person or virtually

5 weeks
4 group sessions (in-person or virtual), 1 individual session

Follow-up

Participants are monitored for depression levels using surveys and electronic health records at multiple time points postpartum

12 months
Surveys at 6 weeks, 3, 6, and 12 months postpartum

What Are the Treatments Tested in This Trial?

Interventions

  • ROSE Program: In Person
  • ROSE Program: Virtual
Trial Overview The study is comparing the effectiveness of a group therapy program called ROSE in preventing postpartum depression when delivered in two ways: face-to-face (in person) and over the internet (virtually).
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Delivery of Group Preventative Intervention (ROSE)Experimental Treatment1 Intervention
Group II: In-Person Delivery of Group Preventative Intervention (ROSE)Active Control1 Intervention

ROSE Program: In Person is already approved in United States for the following indications:

🇺🇸
Approved in United States as ROSE Program for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Denver

Lead Sponsor

Trials
25
Recruited
10,600+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Denver Health Medical Center

Collaborator

Trials
13
Recruited
5,600+

Published Research Related to This Trial

A telephone-based screening protocol for postpartum depression (PPD) was developed and implemented, successfully identifying symptoms in 52% of women screened between 2 and 3 weeks postpartum.
The protocol led to high acceptance rates for referrals, with 64% of women accepting both provider and support services, and follow-through rates of 89% for provider referrals and 78% for support referrals, highlighting the efficacy of early screening and intervention.
Uncovering the Golden Veil: Applying the Evidence for Telephone Screening to Detect Early Postpartum Depression.BenDavid, DN., Hunker, DF., Spadaro, KC.[2020]
A one-day online workshop utilizing cognitive behavioral therapy significantly improved symptoms of postpartum depression and anxiety, as well as enhancing social support and the mother-infant relationship.
This approach offers an efficient way to increase access to treatment for postpartum depression, suggesting it could be a valuable addition to standard care.
One-Day Workshop Beneficial for Postpartum Depression.Rosenberg, K.[2022]
The ROSE sustainment (ROSES) study is evaluating the effectiveness and cost-effectiveness of a stepwise approach to sustaining a postpartum depression prevention program in 90 outpatient clinics, aiming to reduce postpartum depression rates among low-income pregnant women.
This study is the first randomized trial to assess the return on investment (ROI) of sustainment strategies in implementation science, which will provide valuable insights into maintaining effective interventions in clinical settings.
Protocol for the ROSE sustainment (ROSES) study, a sequential multiple assignment randomized trial to determine the minimum necessary intervention to maintain a postpartum depression prevention program in prenatal clinics serving low-income women.Johnson, JE., Wiltsey-Stirman, S., Sikorskii, A., et al.[2023]

Citations

1.samhsa.govsamhsa.gov/
Home | SAMHSA - Substance Abuse and Mental Health ...SAMHSA leads efforts to advance behavioral health across the U.S., offering resources for mental health, substance use, and community well-being.
Informing a decision about ROSE as universal postpartum ...... postpartum depression (PPD; see Table 1) through counseling interventions. The Reach Out, Stay strong, Essentials for mothers of newborns (ROSE) program was ...
The ROSE Sustainment StudyThis program provides pregnant people with the skills and information they need to lower their risk of postpartum depression.
ROSE program aims to prevent postpartum depressionPostpartum depression occurs in around one to seven women. Commonly occurring within six weeks after childbirth, PPD can affect the mother and her ...
Rose Program | Postpartum Depression CareMaternal mental health is a critical component of perinatal care and maternal safety. The ROSE Program (Reach Out, Stay Strong, Essentials for mothers of ...
Treatment of Post-partum Depression Using an Behavioral ...Details for study NCT05518162, | ClinicalTrials.gov.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security